Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Sep 13:8:1134.
doi: 10.3389/fimmu.2017.01134. eCollection 2017.

What Have We Learnt about BCG Vaccination in the Last 20 Years?

Hazel M Dockrell  1 , Steven G Smith  1
Affiliations
Review

What Have We Learnt about BCG Vaccination in the Last 20 Years?

Hazel M Dockrell et al. Front Immunol. .

Abstract

A number of new tuberculosis (TB) vaccines have been or are entering clinical trials, which include genetically modified mycobacteria, mycobacterial antigens delivered by viral vectors, or mycobacterial antigens in adjuvant. Some of these vaccines aim to replace the existing BCG vaccine but others will be given as a boosting vaccine following BCG vaccination given soon after birth. It is clear that the existing BCG vaccines provide incomplete and variable protection against pulmonary TB. This review will discuss what we have learnt over the last 20 years about how the BCG vaccine induces specific and non-specific immunity, what factors influence the immune responses induced by BCG, and progress toward identifying correlates of immunity against TB from BCG vaccination studies. There is still a lot to learn about the BCG vaccine and the insights gained can help the development of more protective vaccines.

Keywords: BCG; biomarkers; correlates of protection; efficacy; immune responses; infants; tuberculosis; vaccination.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Dye C. Making wider use of the world’s most widely used vaccine: bacille Calmette–Guerin revaccination reconsidered. J R Soc Interface (2013) 10:20130365.10.1098/rsif.2013.0365 - DOI - PMC - PubMed
    1. Fletcher HA. Sleeping beauty and the story of the bacille Calmette–Guérin vaccine. MBio (2016) 7:e01370–16.10.1128/mBio.01370-16 - DOI - PMC - PubMed
    1. Scriba TJ, Kaufmann SHE, Henri Lambert P, Sanicas M, Martin C, Neyrolles O. Vaccination against tuberculosis with whole-cell mycobacterial vaccines. J Infect Dis (2016) 214:659–64.10.1093/infdis/jiw228 - DOI - PubMed
    1. Mangtani P, Abubakar I, Ariti C, Beynon R, Pimpin L, Fine PEM, et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin Infect Dis (2014) 58:470–80.10.1093/cid/cit790 - DOI - PubMed
    1. Sterne JA, Rodrigues LC, Guedes IN. Does the efficacy of BCG decline with time since vaccination? Int J Tuberc Lung Dis (1998) 2:200–7. - PubMed